New York Usa India hospital covid-19 patient Updates DOW New York Usa India

Merck's new Covid pill looks to ease hospital strains, boosts Dow. 10 updates

Reading now: 188
www.livemint.com

Here's your 10-point cheat-sheet to this big story: 1. Merck & Co shares posted their biggest gain in 12 years after the company’s experimental pill slashed the risk of getting seriously ill or dying from Covid-19 in a study, findings that could eventually yield a simple way to treat many virus patients before they ever reach the hospital.

The US pharmaceutical company rose as much as 12% in New York trading, its biggest intraday gain since March 13, 2009. 2. The Dow and the S&P 500 oscillated between gains and losses on Friday, as investors weighed a warning from Fitch over the United States' debt ceiling against drugmaker Merck's progress in developing an oral COVID-19 drug.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA